Clozapine and risperidone in moderately refractory schizophrenia / Nina R. Schooler en The Journal of Clinical Psychiatry, Año 2016 - Vol.77 - No.5 (Mayo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 628–634 Título : Clozapine and risperidone in moderately refractory schizophrenia : A 6-Month randomized double-blind comparison Tipo de documento: texto impreso Autores: Nina R. Schooler, Autor ; Stephen R. Marder, Autor ; K. N. R. Chengappa, Autor Fecha de publicación: 2020 Artículo en la página: pp. 628–634 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Clozapina, Administración de medicamentos, Resistencia al medicamento, Trastornos psicóticos, Risperidona, Esquizofrenia. Resumen: Clozapine remains the only medication indicated for refractory schizophrenia. As new antipsychotic drugs become available, their efficacy compared to clozapine, particularly in moderately ill patients, is of great clinical interest. Link: ./index.php?lvl=notice_display&id=21737 [artículo] Clozapine and risperidone in moderately refractory schizophrenia : A 6-Month randomized double-blind comparison [texto impreso] / Nina R. Schooler, Autor ; Stephen R. Marder, Autor ; K. N. R. Chengappa, Autor . - 2020 . - pp. 628–634. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 628–634 Palabras clave: Clozapina, Administración de medicamentos, Resistencia al medicamento, Trastornos psicóticos, Risperidona, Esquizofrenia. Resumen: Clozapine remains the only medication indicated for refractory schizophrenia. As new antipsychotic drugs become available, their efficacy compared to clozapine, particularly in moderately ill patients, is of great clinical interest. Link: ./index.php?lvl=notice_display&id=21737

Paliperidone extended-release in schizoaffective disorder / Carla M. Canuso en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 487-495 Título : Paliperidone extended-release in schizoaffective disorder : A randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers Tipo de documento: texto impreso Autores: Carla M. Canuso, Autor ; Nina R. Schooler, Autor ; Jennifer Carothers, Autor Fecha de publicación: 2022 Artículo en la página: pp. 487-495 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno esquizoafectivo, Paliperidona ER, Antipsicóticos, Antidepresivos, Estabilizadores del estado de ánimo Resumen: This 6-week, double-blind, placebo-controlled study evaluated paliperidone extended-release (ER) as both monotherapy and adjunctive therapy to mood stabilizers and/or antidepressants (MS/ADs) for schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=29420 [artículo] Paliperidone extended-release in schizoaffective disorder : A randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers [texto impreso] / Carla M. Canuso, Autor ; Nina R. Schooler, Autor ; Jennifer Carothers, Autor . - 2022 . - pp. 487-495. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 487-495 Palabras clave: Trastorno esquizoafectivo, Paliperidona ER, Antipsicóticos, Antidepresivos, Estabilizadores del estado de ánimo Resumen: This 6-week, double-blind, placebo-controlled study evaluated paliperidone extended-release (ER) as both monotherapy and adjunctive therapy to mood stabilizers and/or antidepressants (MS/ADs) for schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=29420

Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics) / John M. Kane en The Journal of Clinical Psychiatry, Año 2019 - Vol. 80 - No.3 (Mayo - Junio)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.3 (Mayo - Junio) . - pp. 4-11 Título : Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics) : Results From the Recruitment Phase of the PRELAPSE Trial Tipo de documento: texto impreso Autores: John M. Kane, Autor ; Nina R. Schooler, Autor ; Patricia Marcy, Autor Fecha de publicación: 2019 Artículo en la página: pp. 4-11 Idioma : Inglés (eng) Palabras clave: Esquizofrenia - tratamiento, Acción prolongada, estudio PRELAPSE Resumen: To document the acceptability of treatment with long-acting injectable (LAI) antipsychotic medication to early-phase schizophrenia patients as demonstrated by enrollment in a cluster-randomized LAI clinical trial. Link: ./index.php?lvl=notice_display&id=20826 [artículo] Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics) : Results From the Recruitment Phase of the PRELAPSE Trial [texto impreso] / John M. Kane, Autor ; Nina R. Schooler, Autor ; Patricia Marcy, Autor . - 2019 . - pp. 4-11. Idioma : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.3 (Mayo - Junio) . - pp. 4-11 Palabras clave: Esquizofrenia - tratamiento, Acción prolongada, estudio PRELAPSE Resumen: To document the acceptability of treatment with long-acting injectable (LAI) antipsychotic medication to early-phase schizophrenia patients as demonstrated by enrollment in a cluster-randomized LAI clinical trial. Link: ./index.php?lvl=notice_display&id=20826

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders / Delbert G. Robinson en The American Journal of Psychiatry, Año 2015 - Vol. 172 - No.3 (Marzo)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2015 - Vol. 172 - No.3 (Marzo) . - pp.237-248 Título : Prescription practices in the treatment of first-episode schizophrenia spectrum disorders : data from the national raise-etp study Tipo de documento: texto impreso Autores: Delbert G. Robinson, Autor ; Nina R. Schooler, Autor ; Majnu John, Autor Fecha de publicación: 2020 Artículo en la página: pp.237-248 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Atención médica, Manejo de la Terapia de medicamentos, Esquizofrenia. Resumen: Treatment guidelines suggest distinctive medication strategies for first-episode and multiepisode patients with schizophrenia. To assess the extent to which community clinicians adjust their usual treatment regimens for first-episode patients, the authors examined prescription patterns and factors associated with prescription choice in a national cohort of early-phase patients. Link: ./index.php?lvl=notice_display&id=22257 [artículo] Prescription practices in the treatment of first-episode schizophrenia spectrum disorders : data from the national raise-etp study [texto impreso] / Delbert G. Robinson, Autor ; Nina R. Schooler, Autor ; Majnu John, Autor . - 2020 . - pp.237-248. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2015 - Vol. 172 - No.3 (Marzo) . - pp.237-248 Palabras clave: Antipsicóticos, Atención médica, Manejo de la Terapia de medicamentos, Esquizofrenia. Resumen: Treatment guidelines suggest distinctive medication strategies for first-episode and multiepisode patients with schizophrenia. To assess the extent to which community clinicians adjust their usual treatment regimens for first-episode patients, the authors examined prescription patterns and factors associated with prescription choice in a national cohort of early-phase patients. Link: ./index.php?lvl=notice_display&id=22257

Psychopharmacological Treatment in the RAISE-ETP Study / Delbert G. Robinson en The American Journal of Psychiatry, Año 2018 - Vol. 175 - No. 2 (Febrero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 2 (Febrero) . - pp. 169-179 Título : Psychopharmacological Treatment in the RAISE-ETP Study : Outcomes of a Manual and Computer Decision Support System Based Intervention Tipo de documento: texto impreso Autores: Delbert G. Robinson, Autor ; Nina R. Schooler, Autor ; Christoph U. Correll, Autor Fecha de publicación: 2018 Artículo en la página: pp. 169-179 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Adherencia a los medicamentos, Resultados metabólicos, Psicosis, Esquizofrenia, Efectos secundarios Resumen: The Recovery After an Initial Schizophrenia Episode–Early Treatment Program compared NAVIGATE, a comprehensive program for first-episode psychosis, to clinician-choice community care over 2 years. Quality of life and psychotic and depressive symptom outcomes were found to be better with NAVIGATE. Link: ./index.php?lvl=notice_display&id=13291 [artículo] Psychopharmacological Treatment in the RAISE-ETP Study : Outcomes of a Manual and Computer Decision Support System Based Intervention [texto impreso] / Delbert G. Robinson, Autor ; Nina R. Schooler, Autor ; Christoph U. Correll, Autor . - 2018 . - pp. 169-179. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 2 (Febrero) . - pp. 169-179 Palabras clave: Antipsicóticos, Adherencia a los medicamentos, Resultados metabólicos, Psicosis, Esquizofrenia, Efectos secundarios Resumen: The Recovery After an Initial Schizophrenia Episode–Early Treatment Program compared NAVIGATE, a comprehensive program for first-episode psychosis, to clinician-choice community care over 2 years. Quality of life and psychotic and depressive symptom outcomes were found to be better with NAVIGATE. Link: ./index.php?lvl=notice_display&id=13291

The RAISE Early treatment program for first-episode psychosis / John M. Kane en The Journal of Clinical Psychiatry, Año 2015 - Vol.76 - No.3 (Marzo)

Permalink

---

1 (1 - 6 / 6)